Investment Thesis
Alignment Healthcare demonstrates compelling growth fundamentals with 46% revenue expansion and 99% net income growth, supported by strong free cash flow generation ($121.3M) and a fortress balance sheet with $705.6M cash. However, extremely thin operating margins (1.3%) and weak ROE (5.5%) create vulnerability to cost pressures and limit the sustainability of profitability gains without demonstrable margin expansion.
Strengths
- Exceptional 46.1% YoY revenue growth with 99.4% net income growth demonstrates strong market execution and scaling
- Outstanding free cash flow generation of $121.3M (9.8% FCF margin) despite thin net margins indicates superior cash conversion and business quality
- Solid financial position with $705.6M cash, good liquidity (1.58x current ratio), and manageable leverage (1.56x debt-to-equity)
Risks
- Critically thin operating margin of 1.3% and net margin of 0.9% leave minimal cushion for cost inflation or competitive pricing pressure
- Low return metrics (ROE 5.5%, ROA 0.9%) despite strong growth suggest structural profitability challenges and low economic returns on equity
- Moderate interest coverage ratio (2.9x) combined with elevated debt-to-equity creates vulnerability if revenue growth decelerates or operating conditions deteriorate
Key Metrics to Watch
- Operating margin expansion trajectory as scale increases
- Return on equity improvement and capital efficiency metrics
- Interest coverage ratio and debt service sustainability under stress scenarios
Financial Metrics
Revenue
1.2B
Net Income
11.4M
EPS (Diluted)
$0.05
Free Cash Flow
121.3M
Total Assets
1.3B
Cash
705.6M
Profitability Ratios
Gross Margin
N/A
Operating Margin
1.3%
Net Margin
0.9%
ROE
5.5%
ROA
0.9%
FCF Margin
9.8%
Balance Sheet & Liquidity
Current Ratio
1.58x
Quick Ratio
1.58x
Debt/Equity
1.56x
Debt/Assets
83.6%
Interest Coverage
2.86x
Long-term Debt
323.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T16:50:22.125082 |
Data as of: 2026-03-31 |
Powered by Claude AI